|
1
|
Nestle FO, Kaplan DH and Barker J:
Psoriasis. N Engl J Med. 361:496–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gudjonsson JE and Elder JT: Psoriasis:
Epidemiology. Clin Dermatol. 25:535–546. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rahman M, Alam K, Ahmad MZ, Gupta G, Afzal
M, Akhter S, Kazmi I, Jyoti, Ahmad FJ and Anwar F: Classical to
current approach for treatment of psoriasis: A review. Endocr Metab
Immune Disord Drug Targets. 12:287–302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Menter A, Gottlieb A, Feldman SR, Van
Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA,
Korman NJ, et al: Guidelines of care for the management of
psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis
and guidelines of care for the treatment of psoriasis with
biologics. J Am Acad Dermatol. 58:826–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garshick MK and Kimball AB: Psoriasis and
the life cycle of persistent life effects. Dermatol Clin. 33:25–39.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong Y, Zou J, Su S, Huang H, Deng Y, Wang
B and Li W: MicroRNA-218 and microRNA-520a inhibit cell
proliferation by downregulating E2F2 in hepatocellular carcinoma.
Mol Med Rep. 12:1016–1022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Juan M, Shilong N, Xingxing W, Lu S, Fei
J, Yuan L and Zhong L: The repressive effect of miR-520a on
NF-κB/IL-6/STAT-3 signal involved in the glabridin-induced
anti-angiogenesis in human breast cancer cells. RSC Advances.
5:34257–34264. 2014.
|
|
14
|
Wang X, Wang P, Zhu Y, Zhang Z, Zhang J
and Wang H: MicroRNA-520a attenuates proliferation of Raji cells
through inhibition of AKT1/NF-κB and PERK/eIF2α signaling pathway.
Oncol Rep. 36:1702–1708. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deyrieux AF and Wilson VG: In vitro
culture conditions to study keratinocyte differentiation using the
HaCaT cell line. Cytotechnology. 54:77–83. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Breitkreutz D, Schoop VM, Mirancea N, Baur
M, Stark HJ and Fusenig NE: Epidermal differentiation and basement
membrane formation by HaCaT cells in surfacetransplants. Eur J Cell
Biol. 75:273–286. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Coppo R, Camilla R, Alfarano A, Balegno S,
Mancuso D, Peruzzi L, Amore A, Canton Dal A, Sepe V and Tovo P:
Upregulation of the immunoproteasome in peripheral blood
mononuclear cells of patients with IgA nephropathy. Kidney Int.
75:536–541. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T). Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kumagai-Sano F, Hayashi T, Sano T and
Hasezawa S: Cell cycle synchronizationn of tobacco BY-2 cells. Nat
Protoc. 1:2621–2627. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lei Y, Liu H, Yang Y, Wang X, Ren N, Li B,
Liu S, Cheng J, Fu X and Zhang J: Interaction of LHBs with C53
promotes hepatocyte mitotic entry: A novel mechanism for
HBV-induced hepatocellular carcinoma. Oncol Rep. 27:151–159.
2012.PubMed/NCBI
|
|
21
|
Fu X, Wen H, Jing L, Yang Y, Wang W, Liang
X, Nan K, Yao Y and Tian T: MicroRNA-155-5p promotes hepatocellular
carcinoma progression by suppressing PTEN through the PI3K/Akt
pathway. Cancer Sci. 108:620–631. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meier M and Sheth PB: Clinical spectrum
and severity of psoriasis. Curr Probl Dermatol. 38:1–20. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khurrum H, AlGhamdi KM, Bedaiwi KM and
AlBalahi NM: Multivariate analysis of factors associated with the
koebner phenomenon in vitiligo: An observational study of 381
patients. Ann Dermatol. 29:302–306. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boehncke WH and Schön MP: Psoriasis.
Lancet. 386:983–994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sima J: Dermatology: Illustrated Study
Guide and Comprehensive Board Review. Springer; New York: pp.
83–87. 2012, ISBN: 978-3-319-47395-6.
|
|
26
|
Parisi R, Symmons DP, Griffiths CE and
Ashcroft DM: Identification and Management of Psoriasis and
Associated ComorbidiTy (IMPACT) project team: Global epidemiology
of psoriasis: A systematic review of incidence and prevalence. J
Invest Dermatol. 133:377–385. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tamparo CD and Lewis MA: Diseases of the
Human Body. 5th edition. F.A. Davis Company; Philadelphia, PA: pp.
1802011, ISBN-13: 978-0-8036-2505-1.
|
|
28
|
Krueger G and Ellis CN: Psoriasis-recent
advances in understanding its pathogenesis and treatment. J Am Acad
Dermatol. 53 Suppl 1:S94–S100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nestle FO, Kaplan DH and Barker J:
Psoriasis. N Engl J Med. 361:496–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamamoto S, Yamane M, Yoshida O, Okazaki
M, Waki N, Toyooka S, Oto T and Miyoshi S: Activations of
mitogen-activated protein kinases and regulation of their
downstream moleculesafter rat lung transplantation from donors
after cardiac death. Transplant Proc. 43:3628–3633. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smith CH and Barker JN: Psoriasis and its
management. BMJ. 333:380–384. 2015. View Article : Google Scholar
|
|
32
|
Prieto-Pérez R, Cabaleiro T, Daudén E,
Ochoa D, Roman M and Abad-Santos F: Genetics of Psoriasis and
Pharmacogenetics of Biological Drugs. Autoimmune Dis.
2013:6130862013.PubMed/NCBI
|
|
33
|
Beaudoin GM: Mosaic cellular patterning in
the nose: Adhesion molecules give their two scents. J Cell Biol.
212:495–497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choi EK, Jang HC, Kim JH, Kim HJ, Kang HC,
Paek YW, Lee HC, Lee SH, Oh WM and Kang IC: Enhancement of
cytokine-mediated NF-kappaB activation by phosphatidylinositol
3-kinase inhibitors inmonocytic cells. Int Immunopharmacol.
6:908–915. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
